Overexpression of proteasome 26S subunit non-ATPase 6 protein and its clinicopathological significance in intrahepatic cholangiocarcinoma
Year: 2024
Type: article
Study design: Observational Study
Abstract: BACKGROUND: Currently, intrahepatic cholangiocarcinoma (ICC) poses a continuing, significant health challenge, but the relationship has yet to be established between ICC and the proteasome 26S subunit non-ATPase 6 (PSMD6). AIM: To investigate the protein expression and clinicopathological significance of PSMD6 in ICC. METHODS: gene on the growth of ICC cell lines was analyzed using clustered regularly interspaced short palindromic repeat knockout screening technology. Forty-two paired specimens of ICC and adjacent non-cancerous tissues were collected. PSMD6 protein expression was determined by immunohistochemistry. Receiver operating characteristic curve analysis was performed to validate PSMD6 expression level, and its association with ICC patients' various clinicopathological characteristics was investigated. RESULTS: > 0.05). CONCLUSION: PSMD6 can promote the growth of ICC cells, thus playing a pro-oncogenic role.
Source: World Journal of Hepatology
Authors: Zhong-Qing Tang, Yu-Lu Tang, Kai Qin, Qi Li, Gang Chen, Yu-Bin Huang, Jian-Jun Li
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
Funders: Hokkaido University, Ono Pharmaceutical
OpenAlex ID: W4404028123
